GEN Exclusives

More »

The Lists

More »
Aug 21, 2012

Top 10 Pharma Firms

Check out which companies made the list.

Top 10 Pharma Firms

These are the ten pharmaceutical companies pulling in the most dollars. [© Pavel Ignatov - Fotolia.com]

  • Below are Top 10 pharmaceutical companies based on market capitalization at the end of the second quarter 2012, and the year-ago quarter, calculated by multiplying the number of outstanding shares by the share price. U.S. companies generally report their numbers of outstanding shares in their 10-Q quarterly earnings filings with the Securities & Exchange Commission. Companies based outside the U.S. either disclose market cap directly, or their numbers of shares “in issue” or “in free issue” in half-year and full-year results disclosures.

    For all companies, closing share prices as of the dates of their outstanding-shares figures can be found through any of several free stock information websites. Figures of non-U.S. companies were converted from various currencies.

  • #10. AstraZeneca

    2012 Market Cap: $56.34 billion (6/30: 1.259 million shares * 6/29 price $44.75)

    2011 Market Cap: $68.40 billion (6/30: 1.366 million shares * 6/30 price $50.07)

    % Change: -17.6%

  • #9. Bristol-Myers Squibb

    2012 Market Cap: $60.36 billion (6/30: 1,679,022,076 shares * 6/29 price $35.95)

    2011 Market Cap: $49.40 billion (6/30: 1,705,666,684 shares * 6/30 price $28.96)

    % Change: 22.2%

  • #8. Sanofi1

    2012 Market Cap: $96.99 billion (6:30: 1,321,852,008 shares * 6/29 price €59.74 = €78,967,438,957.92)

    2011 Market Cap: $91.95 billion (€E74.865 billion)

    % Change: 4.7%

  • #7. Abbott Laboratories

    2012 Market Cap: $101.17 billion (6/30: 1,569,333,729 shares * 6/29 price $64.47)

    2011 Market Cap: $81.91 billion (6/30: 1,556,576,533 shares * 6/30 price $52.62)

    % Change: 23.5%

  • #6. GlaxoSmithKline2

    2012 Market Cap: $111.45 billion (4.91M shares *1,447p /100 & convert)

    2011 Market Cap: $105.37 billion (5.036M shares *1,334p /100 & convert)

    % Change: 5.8%

  • #5. Novartis3

    2012 Market Cap: $133.9 billion

    2011 Market Cap: $150.1 billion

    % Change: -10.8%

  • #4. Merck & Co.

    2012 Market Cap: $134.53 billion (7/31: 3,045,632,274 shares * price $44.17)

    2011 Market Cap: $105.15 billion (7/29: 3,080,796,992 shares * price $34.13)

    % Change: 27.9%

  • #3. Roche4

    2012 Market Cap: $142.94 billion (CHF: 139.737M)

    2011 Market Cap: $123.35 billion (CHF: 120.587M)

    % Change: 15.9%

  • #2. Pfizer

    2012 Market Cap: $181.21 billion (8/6: 7,469,483,622 shares * price $24.26)

    2011 Market Cap: $129.98 billion (8/8: 7,802,126,616 shares * price $16.66)

    % Change: 39.4%

  • #1. Johnson & Johnson

    2012 Market Cap: $191.67 billion (7/27: 2,757,041,143 shares * price $69.52)

    2011 Market Cap: $177.55 billion (7/29: 2,740,354,114 shares * price $64.79)

    % Change: 8.0%

  •  

    Leave a comment by clicking the “Comments” icon. We want to hear your thoughts!


Readers' Comments

Posted 08/22/2012 by Susan Light

It would be interesting to see the number of employess listed along with the market cap.

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Megamerger Dealzapoppin Poll

What company not in this week’s M&A headlines do you think will be at the center of a megamerger, acquisition, or partial selloff this year?